1.
Consensus summary report for CEPI/BC March 12–13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines
by Lambert, Paul-Henri
Vaccine, 2020-06-26, Vol.38 (31), p.4783-4791
2.
BCG vaccine may generate cross-reactive T cells against SARS-CoV-2: In silico analyses and a hypothesis
by Tomita, Yusuke
Vaccine, 2020-09-22, Vol.38 (41), p.6352-6356
3.
COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
by Roncati, Luca
Vaccine, 2020-11-10, Vol.38 (48), p.7581-7584
4.
A serological assay to detect SARS-CoV-2 seroconversion in humans
by Amanat, Fatima
Nature medicine, 2020-07, Vol.26 (7), p.1033-1036
5.
Antibody responses to SARS-CoV-2 in patients with COVID-19
by Long, Quan-Xin
Nature medicine, 2020-06, Vol.26 (6), p.845-848
6.
The epidemiology and clinical information about COVID-19
by Ge, Huipeng
European journal of clinical microbiology & infectious diseases, 2020-04-14, Vol.39 (6), p.1011-1019
7.
Seasonal coronavirus protective immunity is short-lasting
by Eidge, Arthur W. D
Nature medicine, 2020-11, Vol.26 (11), p.1691-1693
8.
Risk of COVID-19 for patients with cancer
by Xia, Yang
The lancet oncology, 2020-04, Vol.21 (4), p.e180-e180
9.
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
by Long, Quan-Xin
Nature medicine, 2020-08, Vol.26 (8), p.1200-1204
10.
Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy
by Giordano, Giulia
Nature medicine, 2020-06, Vol.26 (6), p.855-860
11.
Age-dependent effects in the transmission and control of COVID-19 epidemics
by Davies, Nicholas G
Nature medicine, 2020-08, Vol.26 (8), p.1205-1211
12.
The genetic sequence, origin, and diagnosis of SARS-CoV-2
by Wang, Huihui
European journal of clinical microbiology & infectious diseases, 2020-04-24, Vol.39 (9), p.1629-1635
13.
Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding
by Xu, Yi
Nature medicine, 2020-04, Vol.26 (4), p.502-505
14.
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein
by Zost, Seth J
Nature medicine, 2020-09, Vol.26 (9), p.1422-1427
15.
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
by Xie, Xuping
Nature medicine, 2021-04, Vol.27 (4), p.620-621
16.
The proximal origin of SARS-CoV-2
by Andersen, Kristian G
Nature medicine, 2020-04, Vol.26 (4), p.450-452
17.
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
by Chen, Rita E
Nature medicine, 2021-04, Vol.27 (4), p.717-726
18.
Temporal dynamics in viral shedding and transmissibility of COVID-19
by He, Xi
Nature medicine, 2020-05, Vol.26 (5), p.672-675
19.
Extrapulmonary manifestations of COVID-19
by Gupta, Aakriti
Nature medicine, 2020-07, Vol.26 (7), p.1017-1032
20.
Determinants of COVID-19 disease severity in patients with cancer
by Robilotti, Elizabeth V
Nature medicine, 2020-08, Vol.26 (8), p.1218-1223
